
Rapamycin inhibits mTORC1 kinase activity leading to TFEB dephosphorylation and nuclear translocation, dramatically upregulating lysosomal biogenesis genes including LAMP1, LAMP2, and cathepsin D. Enhanced autophagy flux promotes clearance of accumulated Gb3 deposits while rapamycin's anti-inflammatory properties reduce chronic activation of microglia and astrocytes in Fabry neuropathy.
IPFS: QmdfCcHKnTM2aAt7KR6ybZcnPSnU2sG7ssZ7k3LAPG5qFn. TX: 0x379ed02897a02e0740bfc3be55b9dc4084b740ef0129647c671b13600b27d3e9. CC0.
Fabry disease, drug repurposing, MedicOath, repurposing
Fabry disease, drug repurposing, MedicOath, repurposing
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
